secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001297184-23-000007
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar Pharmaceuticals amends bylaws to update director nomination procedures and adopt forum selection clause
--------------------------------------------------------------------------------

- Board approved Amended and Restated Bylaws on Feb 23, 2023.
- New requirement for stockholders to deliver evidence of compliance with Rule 14a-19 no later than five business days before meeting.
- Adopted forum selection provision for claims under the Securities Act of 1933.
- Updated provisions on directors, committees, officers, and conformed to Delaware General Corporation Law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718423000007/0001297184-23-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718423000007/amph-20230223x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-23-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer